Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Low-dose long-acting insulin in non-diabetic adults with cystic fibrosis
NL-OMON38361Active, not recruiting
- Sponsor
- HagaZiekenhuis
- Start
- Jul 2012
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Randomised trial in cystic fibrosis (CF) comparing Long-acting insulin with Placebo (2 arms). Primary endpoints: Body weight and Body mass index. Started Jul 2012; status: active, not recruiting.
02
Drugs
human insulin
03
Conditions
cystic fibrosis (CF)
Beyond the preview
Go deeper on NL-OMON38361.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON38361.